Nano-formulations for pulmonary delivery: Past, present, and future perspectives

S Peng, W Wang, R Zhang, C Wu, X Pan, Z Huang - Pharmaceutics, 2024 - mdpi.com
With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …

[HTML][HTML] Drug repurposing against coronavirus disease 2019 (COVID-19): A review

L Luo, Q Qiu, F Huang, K Liu, Y Lan, X Li… - Journal of …, 2021 - Elsevier
Since December 2019, severe acute respiratory syndrome coronavirus 2 has been found to
be the culprit in the coronavirus disease 2019 (COVID-19), causing a global pandemic …

Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points

L Pinilla, ID Benitez, J Gonzalez, G Torres, F Barbe… - RNA biology, 2021 - Taylor & Francis
The COVID-19 emergency pandemic resulting from infection with SARS-CoV-2 represents a
major threat to public health worldwide. There is an urgent clinical demand for easily …

Coronaviruses: Sars, Mers and Covid-19

EJ Kim, D Lee - Korean Journal of Clinical Laboratory Science, 2020 - koreascience.kr
Coronaviruses were originally discovered as enzootic infections that limited to their natural
animal hosts, but some strains have since crossed the animal-human species barrier and …

The diagnostic accuracy of SARS-CoV-2 nasal rapid antigen self-test: A systematic review and meta-analysis

E Karlafti, D Tsavdaris, E Kotzakioulafi, G Kaiafa… - Life, 2023 - mdpi.com
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause
of coronavirus disease 2019 (COVID-19), a disease that quickly spread into a pandemic. As …

Multiple sclerosis patients and disease modifying therapies: impact on immune responses against COVID-19 and SARS-CoV-2 vaccination

M Golshani, J Hrdý - Vaccines, 2022 - mdpi.com
This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS).
The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 …

Myocardial injury in COVID-19 and its implications in short-and long-term outcomes

A Izquierdo-Marquisa, H Cubero-Gallego… - Frontiers in …, 2022 - frontiersin.org
COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still
a pandemic with high mortality and morbidity rates. Clinical manifestation is widely variable …

The relationship between intolerance of uncertainty, coping style, resilience, and anxiety during the COVID-19 relapse in freshmen: A moderated mediation model

T Wang, L Jiang, T Li, X Zhang, S Xiao - Frontiers in Psychiatry, 2023 - frontiersin.org
Background The repeated outbreaks of COVID-19 and the rapid increase in uncertainty
have had many negative effects on the public's mental health, especially on emotional …

The threat of adversarial attack on a COVID-19 CT image-based deep learning system

Y Li, S Liu - Bioengineering, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) rapidly spread around the world, and resulted in
a global pandemic. Applying artificial intelligence to COVID-19 research can produce very …

Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range

K Winkley, D Banerjee, T Bradley, B Koseva… - Scientific Reports, 2021 - nature.com
Previous studies focusing on the age disparity in COVID-19 severity have suggested that
younger individuals mount a more robust innate immune response in the nasal mucosa after …